Hemgenix continues to be given ‘conditional authorisation’. Consequently the European Medicines Agency decided that the key benefits of Hemgenix are greater than its pitfalls, but the company must offer added evidence following authorisation. When given to the individual, the virus will carry the issue IX gene towards the liver cells, https://eddiew346pqq9.wikicommunications.com/user